Advances in Oral Squamous Cell Carcinoma: Pathogenesis, Risk Factors
DOI:
https://doi.org/10.61173/sve7ct94Keywords:
Oral Squamous Cell Carcinoma, tumor mi-croenvironment, targeted therapy, risk factorsAbstract
mwymwAbstract: Among many types of Oral Cancer, Oral Squamous cell carcinoma(OSCC) is one of the most significant malignant tumors in the world. When more research is done into the molecular pathogenesis behind tumor initiation and progression, there is an opportunity to discover targeted therapies that are more effective for treatment. Moreover, in the study of tumor microenvironment,the interaction among cancer cells and surrounding stroma or immune cells, is also still not well understood. Understanding the interactions between molecules in the tumor microenvironment has important implications for the study of new therapeutic targets. The symptoms, pathogenesis and risk factor of OSCC as well as the existing therapeutic methods were studied in this paper. Because there are no obvious symptoms in the early stages of OSCC, it is important to know it for the treatment of OSCC. Risk factor also discussed the main causes of OSCC, which also can be contributed to the subsequent research. In this paper, common and popular therapies are listed. nanotechnology-based drug delivery is one of the most novel and effective therapies available today. This method offers the possibility of delivering chemotherapy or targeted drugs directly to OSCC. This reduces systemic side effects and provides precision. This technology has shown amazing effects in the clinical scope and is gradually being used in treatment.
References
[1] Tan, Yunhan, et al. Oral squamous cell carcinomas: state of the field and emerging directions. International journal of oral science, 2023, 15(1): 44.
[2] Mello, Fernanda Weber, et al. Prevalence of Oral Potentially Malignant Disorders: A Systematic Review and Meta‐analysis. Journal of Oral Pathology and Medicine, 2018, 47(7): 633-640.
[3] Mao, Li, et al. Frequent Microsatellite Alterations at Chromosomes 9p21 and 3p14 in Oral Premalignant Lesions and Their Value in Cancer Risk Assessment. Nature Medicine, 1996, 2(6): 682-685.
[4] Cui, Juan-Juan, et al. Expression and Significance of P53 and Mdm2 in Patients With Leukoplakia Cancer. Asian Pacific Journal of Tropical Medicine, 2013, 6(10): 831-834.
[5] Qin, et al. A high prevalence of p53 mutations in premalignant oral erythroplakia. PubMed, 1999.
[6] Chamoli, Ambika, et al. Overview of Oral Cavity Squamous Cell Carcinoma: Risk Factors, Mechanisms, and Diagnostics. Oral Oncology, 2021, 121: 105451.
[7] Ko, Ying‐Chin, et al. Betel Quid Chewing, Cigarette Smoking and Alcohol Consumption Related to Oral Cancer in Taiwan. Journal of Oral Pathology and Medicine, 1995, 24(10): 450-453.
[8] Lin, Wen-Jiun, et al. Smoking, Alcohol, and Betel Quid and Oral Cancer: A Prospective Cohort Study. Journal of Oncology, 2011: 1-5.
[9] Goldberg, Manijeh, et al. A Nanoengineered Topical Transmucosal Cisplatin Delivery System Induces Anti-tumor Response in Animal Models and Patients With Oral Cancer. Nature Communications, 2022, 13(1).
[10] Hiraishi, Yukihiro, et al. EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines. Pathology & Oncology Research, 2008, 14(1): 39-43.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.

This work is licensed under a Creative Commons Attribution 4.0 International License.
